![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.tbl1.png)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors - Timmerman - 2021 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors - Timmerman - 2021 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library](https://obgyn.onlinelibrary.wiley.com/cms/asset/d5808b7e-6500-4bc7-b365-36846ba59089/uog23635-fig-0003-m.jpg)
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumors - Timmerman - 2021 - Ultrasound in Obstetrics & Gynecology - Wiley Online Library
![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen. - ppt download Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen. - ppt download](https://images.slideplayer.com/34/10165346/slides/slide_2.jpg)
Introduction and overview of CA19-9 CA19-9 is a tumour associated antigen found in the blood serum. CA 19-9 is also known as the Sialylated Lewis-antigen. - ppt download
![Evolving Role of Serum Biomarkers in the Management of Ovarian Cancer - Angiolo Gadducci, Stefania Cosio, Giulia Zanca, Andrea Riccardo Genazzani, 2006 Evolving Role of Serum Biomarkers in the Management of Ovarian Cancer - Angiolo Gadducci, Stefania Cosio, Giulia Zanca, Andrea Riccardo Genazzani, 2006](https://journals.sagepub.com/cms/10.2217/17455057.2.1.141/asset/images/large/10.2217_17455057.2.1.141-table5.jpeg)
Evolving Role of Serum Biomarkers in the Management of Ovarian Cancer - Angiolo Gadducci, Stefania Cosio, Giulia Zanca, Andrea Riccardo Genazzani, 2006
![Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers](https://www.frontiersin.org/files/Articles/1158330/fmolb-10-1158330-HTML-r2/image_m/fmolb-10-1158330-g001.jpg)
Frontiers | Stratification of ovarian cancer borderline from high-grade serous carcinoma patients by quantitative serum NMR spectroscopy of metabolites, lipoproteins, and inflammatory markers
![IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite IJMS | Free Full-Text | CA 19-9 Pancreatic Tumor Marker Fluorescence Immunosensing Detection via Immobilized Carbon Quantum Dots Conjugated Gold Nanocomposite](https://pub.mdpi-res.com/ijms/ijms-19-01162/article_deploy/html/images/ijms-19-01162-sch003.png?1570011465)